# LATAM LOWERS LDL-C

> **NCT06501443** · PHASE4 · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 520 (estimated)

## Conditions studied

- Hypercholesterolaemia

## Interventions

- **DRUG:** Usual care
- **DRUG:** KJX839

## Key facts

- **NCT ID:** NCT06501443
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-11
- **Primary completion:** 2026-11-27
- **Final completion:** 2026-11-29
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06501443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06501443, "LATAM LOWERS LDL-C". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06501443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*